Answer
It is unknown whether tenecteplase (Metalyse) passes into human breast milk, so caution is required when treating a nursing woman and a decision must be made about discontinuing breastfeeding within the first 24 hours after administration.
Sources for this answer
- Metalyse 10,000 unitsBoehringer Ingelheim Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked